t:slim X2 Insulin Pump with Basal-IQ Technology

FDA Premarket Approval P180008 S007

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

Approval of a rework process change related to the assembling of the printed circuit board assembly (pcba) at a tandem supplier. The pcba is a component of the tandem t:slim x2 insulin pump system

Devicet:slim X2 Insulin Pump with Basal-IQ Technology
Generic NameAutomated Insulin Dosing , Threshold Suspend
ApplicantTandem Diabetes Care, Inc.
Date Received2019-11-20
Decision Date2019-12-19
PMAP180008
SupplementS007
Advisory CommitteeClinical Chemistry
Supplement Type30-day Notice
Supplement ReasonProcess Change - Manufacturer/sterilizer/packager/supplier
Expedited ReviewNo
Combination Product No
Applicant Address Tandem Diabetes Care, Inc. 11075 Roselle Street san Diego, CA 92121

Supplemental Filings

Supplement NumberDateSupplement Type
P180008Original Filing
S007 2019-11-20 30-day Notice
S006 2018-09-27 30-day Notice
S005 2018-09-12 30-day Notice
S004
S003 2018-08-31 Real-time Process
S002 2018-08-31 Real-time Process
S001 2018-08-31 Real-time Process

NIH GUDID Devices

Device IDPMASupp
00853052007325 P180008 000
00853052007301 P180008 000
00853052007288 P180008 000
00853052007264 P180008 000
00850006613380 P180008 000
00850006613373 P180008 000

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.